ReadytoDrink Cocktails Poised for Continued Growth in 2026 as Consumer Preferences Shift JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook Intel Trading Volume Under Scrutiny Is INTC Among the Most Traded US Stocks in 2026 TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom SpaceXs Rocket Dominance May Give It an IPO Edge Over OpenAI Microns Monthly Surge Echoes 1987 Rally Analysts Flag Potential Value Opportunity DX Q1 2026 Earnings EPS Misses Estimates Amid Interest Rate Volatility AXP Q1 2026 Earnings EPS Beat of 533 Highlights Resilient Spending PAR Technology Q1 2026 Earnings Strong EPS Surprise Highlights Operational Efficiency Universal Technical Institute Inc UTI Q1 2026 Earnings EPS Misses Estimates Amid Enrollment Headwinds Pyxis Oncology Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Sentiment ALOT Q1 2026 Earnings Negative EPS Amidst Strategic Transitions Urban Outfitters URBN Shares Slip 1 as Retail Sector Faces Headwinds Block Inc XYZ Posts Strong Gains as Shares Approach Key Resistance Zone IBM Stock Gains 18 as Shares Approach Key Resistance Technical and Sector Analysis Raymond James Financial RJF Slips 113 as Investors Weigh Resistance at 15083 Hovnanian Enterprises HOV Gains 159 as Homebuilder Sector Sees Renewed Momentum Mercury Achieves 52 Billion Valuation Amid Fintech Sector Resurgence BBGI Q4 2025 Earnings Deep Loss Reported as Stock Edges Higher Amid Sparse Data Great Elm Group Notes GEGGL Steady at 2454 as FixedIncome Investors Seek Yield QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies LIXT Q4 2024 Earnings Biotech Reports Net Loss Stock Declines Heidmar Maritime Holdings Corp HMR Q4 2025 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 29 JAKK Q1 2026 Earnings EPS Surprises Positive but Revenue Details Absent Stock Dips NEGG Q4 2022 Earnings Sharp EPS Miss Overshadows Modest Stock Uptick QS Q1 2026 Earnings Narrower Loss Surprises But Stock Falls 215 Amid Continued PreRevenue Phase RenovoRx Inc RNXT Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Holds Steady